a decreasing trendp < .0001
A decreasing trend was also found for NNRTI mutations, which dropped from 77.8% to 53.8% (p < .0001).
A decreasing trend was also found for NNRTI mutations, which dropped from 77.8% to 53.8% (p < .0001).
In contrast, an increasing trend was observed for lopinavir (from 25.0% to 28.1%, p = .012), fosamprenavir (from 0% to 7.0%, p < .0001), atazanavir (from 2.3% to 23.8%, p < .0001), darunavir (from 0% to 16.3%, p < .0001), and tipranavir (from 0.6% to 1.6%, p < .0001).